Category Archive: Pharmaceutical Litigation

Prescription drugs are meant to help patients recover from or cope with encumbering medical conditions. Unfortunately, not all prescription drugs are made or distributed with patients’ best interests in mind; many cause undue harm, injury, and even death. If you are the victim of a pharmaceutical drug that’s caused you harm that you would not have suffered but for the medication, you have the right to pursue a civil action. At Napoli Shkolnik, PLLC our attorneys can help you to determine who is liable for your injuries, and file a claim to recover damages for economic and noneconomic losses.

Hip Replacement Metal Poisoning Prompts Concern

Hip Replacement Metal Poisoning Prompts Concern

| Pharmaceutical Litigation
A watchdog agency’s failure to ask questions may be the main reason many of these devices have high levels of cobalt and other dangerous metals. In the only extensive study of this problem to date, researchers found that 100 percent of hip implant patients whose devices failed had symptoms of depression, and in about a…Read the article
How Chemotherapy Treatment Can Lead to Permanent Hair Loss

How Chemotherapy Treatment Can Lead to Permanent Hair Loss

| Pharmaceutical Litigation
For the millions of men and women who have had to suffered from hair loss, it is an aggravating, depressing and embarrassing condition, regardless of whether it is caused by illness, injury, hereditary conditions, trauma, or medication side effects. While all these hair loss conditions are different, they all have a damaging effect on the…Read the article
Health Risks and Concerns Regarding Invokana

Health Risks and Concerns Regarding Invokana

| Pharmaceutical Litigation
Invokana, medically known by the drug name canagliflozin, is a sodium-glucose co-transporter 2 inhibitor and is being prescribed to help control blood sugar in people with Type 2 Diabetes. It is used as part of a treatment plan and is used in addition to diet and exercise when results are not being seen and levels are…Read the article
Can Benzene Be Found In Paint?

Can Benzene Be Found In Paint?

| Pharmaceutical Litigation
Are you a regular user of detergent and dyes, bug sprays, and synthetic fibers? What about decorative paints and paint thinners? Nothing odd, millions of others use them too. They do make our lives convenient, scented, and colorful, after all. There’s nothing unsafe or unhealthy about them, right? Unfortunately, wrong. All of these products contain dozens…Read the article
What Is the FDA Approval Process?

What Is the FDA Approval Process?

| Pharmaceutical Litigation
Before a prescription drug can be sold in the United States, it must go through a rigorous approval process managed by the U.S. Food and Drug Administration (FDA). The point of the approval process is to test the drug in various ways and determine both its efficacy and any risks or dangers it poses. Here’s…Read the article
Federal Regulators Approve Smart Pill

Federal Regulators Approve Smart Pill

| Pharmaceutical Litigation
MyCite tablets from Abilify may help doctors give better care to their patients, and they also has some interesting legal implications for dangerous drug cases. The aripiprazole tablets, which the Food and Drug Administration has approved for treatment of manic depression and schizophrenia, have tiny ingestible sensors. When the patient swallows the tablet, the sensor…Read the article
DEA Sponsors National Prescription Take Back Day

DEA Sponsors National Prescription Take Back Day

| Opioid Crisis
The Drug Enforcement Administration is encouraging New Yorkers to clear out their medicine cabinets and turn in unused pain pills and other prescription medications, with no questions asked. The last such event, in April 2017, netted over 450 tons of prescription drugs at over 5,000 nationwide sites. SInce the program began in September 2010, officials…Read the article
Shayna Sacks Appointed to Leadership Role in PPI Litigation

Shayna Sacks Appointed to Leadership Role in PPI Litigation

| Pharmaceutical Litigation
Napoli Shkolnik PLLC is proud to announce that Partner Shayna E. Sacks was named to the Plaintiffs’ Steering Committee in the In Re: Proton-Pump Inhibitor Products Liability Litigation (MDL 2789) by United Stated District Judge Claire C. Cecchi of the District of New Jersey. Ms. Sacks brings her substantial mass tort legal acumen and experience…Read the article
Rheumatoid Arthritis: Actemra Lawsuits

Rheumatoid Arthritis: Actemra Lawsuits

| Pharmaceutical Litigation
Actemra is a prescription drug that is given to patients to treat rheumatoid arthritis. While the drug is supposed to help patients overcome their pain and limitations caused by the disease, Actemra (active ingredient tocilizumab) has been linked to serious side effects, and many affected patients have taken action by filing lawsuits against Roche., Actemra’s…Read the article
New Actemra Clinical Trials Move Forward

New Actemra Clinical Trials Move Forward

| Pharmaceutical Litigation
Even as questions swirl about the drug’s safety, Roche subsidiary Genentech announced that its plans to market Actemra to sclerosis patients will move to Phase 3 clinical trials. Over the next 48 weeks, Genentech employees at over 100 worldwide sites will administer either tocilizumab or placebos to test subjects who have been diagnosed with systemic…Read the article
GET HELP NOW